Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-13 · accession 0001593968-23-001013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-15 | 2023-06-13 | ALLO | MESSEMER DEBORAH M. | Dir | A - Grant | $0.00 | +74.6K | 81.1K | +1,141% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-13 | A | A | 74,561 | $0.00 | 81,096 | D | — | — |